Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cancer Genetics Inc (CGIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer

Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the appointment Michael McCartney as the Company's Chief...

CGIX : 0.90 (-9.09%)
Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Cancer Genetics, Inc. (CGIX)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the June 4, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Cancer...

CGIX : 0.90 (-9.09%)
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 4, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cancer Genetics, Inc. ("Cancer Genetics" or ''the Company'')...

CGIX : 0.90 (-9.09%)
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018

NEW YORK, NY / ACCESSWIRE / June 4, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Cancer Genetics, Inc. (''Cancer Genetics'' or the ''Company'')...

CGIX : 0.90 (-9.09%)
3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 1, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cancer Genetics, Inc. ("Cancer Genetics" or ''the Company'')...

CGIX : 0.90 (-9.09%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX

NEW YORK, NY / ACCESSWIRE / June 1, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Cancer Genetics, Inc. ("Cancer Genetics" or the "Company") (NASDAQ: CGIX) and certain...

CGIX : 0.90 (-9.09%)
CANCER GENETICS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in Cancer Genetics, Inc. to Contact the Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cancer Genetics, Inc. ("Cancer Genetics" or the "Company") (NASDAQ: CGIX) of the June 4, 2018 deadline to...

CGIX : 0.90 (-9.09%)
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Cancer Genetics, Inc. (CGIX) and Encourages Investors to Contact the Firm Before June 4th

Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or...

CGIX : 0.90 (-9.09%)
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 31, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cancer Genetics, Inc. ("Cancer Genetics" or ''the Company'')...

CGIX : 0.90 (-9.09%)
Safirstein Metcalf LLP Reminds Investors That A Class Action Has Been Filed Against Cancer Genetics, Inc. - CGIX

Safirstein Metcalf LLP, reminds investors that a class action lawsuit was filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise...

CGIX : 0.90 (-9.09%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX

Pomerantz LLP announces that a class action lawsuit has been filed against Cancer Genetics, Inc. ("Cancer Genetics" or the "Company") (NASDAQ: CGIX) and certain of its officers. The class...

CGIX : 0.90 (-9.09%)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018

NEW YORK, NY / ACCESSWIRE / May 30, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Cancer Genetics, Inc.("Cancer Genetics" or the "Company") (NASDAQ:...

CGIX : 0.90 (-9.09%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX

NEW YORK, NY / ACCESSWIRE / May 26, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Cancer Genetics, Inc. ("Cancer Genetics" or the "Company") (NASDAQ: CGIX) and certain...

CGIX : 0.90 (-9.09%)
Complimentary Technical Snapshots on Bruker and Three More Medical Research Stocks

Stock Research Monitor: BEAT, CGIX, and CHEK

BEAT : 46.05 (-0.54%)
CGIX : 0.90 (-9.09%)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018

NEW YORK, NY / ACCESSWIRE / May 16, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Cancer Genetics, Inc.("Cancer Genetics" or the "Company") (NASDAQ:...

CGIX : 0.90 (-9.09%)
DEADLINE ALERT: Shareholder Class Action Filed Against Cancer Genetics, Inc. - CGIX

RADNOR, PA / ACCESSWIRE / May 15, 2018 / Kaskela Law LLC reminds Cancer Genetics, Inc. (NASDAQ: CGIX) ("Cancer Genetics" or the "Company") shareholders that a class action lawsuit has been filed on behalf...

CGIX : 0.90 (-9.09%)
Cancer Genetics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 15, 2018 / Cancer Genetics, Inc. (NASDAQ: ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 15, 2018 at 8:30 AM Eastern Time.

CGIX : 0.90 (-9.09%)
Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates

Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced financial and operating results for the first quarter...

CGIX : 0.90 (-9.09%)
Cancer Genetics to Report First Quarter 2018 Financial Results on May 15, 2018

Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that it will release its financial results for the first...

CGIX : 0.90 (-9.09%)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) & Lead Plaintiff Deadline - June 4, 2018

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Cancer Genetics, Inc. ("Cancer Genetics" or the "Company") (NASDAQ:CGIX) and certain...

CGIX : 0.90 (-9.09%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC -2.19 , FTNT -0.81 , CAKE -2.16 , PLT -0.20 , AEO -0.88
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed Friday steady to fractionally mixed, as July was down 1.11% on the week. The USDA reported a private export sale of 131,300 MT of corn to Mexico this morning. The sale was broke down to 30,000 MT for delivery in 2017/18, with the ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar